Beam Therapeutics Inc.'s (NASDAQ:BEAM) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures

featured-image

Key Insights Given the large stake in the stock by institutions, Beam Therapeutics' stock price might be vulnerable to...

Key Insights Given the large stake in the stock by institutions, Beam Therapeutics' stock price might be vulnerable to...

.